Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized study of ozone vaginal lavage versus active comparators for nonspecific vaginitis
ChiCTR-IPR-14005426Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Mar 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bacterial vaginosis (BV) comparing Baofukang suppository, Ozone liquid and 3% boric acid (3 arms). Primary endpoints: Signs and symptoms, Drug onset time and 1 more. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
medical ozonated waterbaofukang shuanboric acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR-IPR-14005426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005426.